slight beat overshadow flat ep guid
quick take focu today guidanc walgreen deliv exactli said
ep roughli flat y-o-i w/fx impact given eye like exact
contribut margin capit deploy etc call quarter na came slightli ahead
expect pharmaci fe compstore intern retail weak weak uk retail rx
pharmaceut wholesal beat look gross margin fell bp y-o-i bp declin
na bp declin retail intern opex crept slightli revenu oper
margin declin bp though look forward rais cost restructur plan form bn
bn prior line lower-than-expect tax rate boost ep separ
expand list partnership announc new agreement open jenni craig walgreen locat
state wba result like better mani fear today stock reaction like depend
manag commentari call
revenu comp revenu came street close bp retail pharmaci usa slightli
expect wholesal gener line bit wors
neutral us retail pharmaci fill mm rx vs estim mm
neg intern retail c/c growth comp basi includ retail sale declin
boot uk maintain share retail market remain challeng
posit wholesal grew compar c/c basi vs estim
industri color reimburs pressur declin gener profit fe pressur remain main stori drug store
margin in-lin consensu though bp y-o-i na retail bp bp
wholesal bp opex rose sale bp y-o-i in-lin sequenti help drive om
interest tax contribut mm quarter lower-than-expect tax rate help ep
continu guidanc cc focu
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
ep convers ep came in-lin estim convers came
bn vs bn
guidanc color compani today introduc guidanc roughli flat growth fiscal adjust earn per share
constant currenc rate rang exclud impact lower fiscal bonu pay-out expect
topic cc
guidanc compon gm progress ebit growth capit deploy
updat effort off-set reimburs headwind particularli gener procur
updat view uk retail given on-going brexit uncertainty/restructur
increment color current partnership updat thought evolut front end
progress digit sourc restructur increas
date/tim octob et webcast
valuat methodolog base mix discount cash flow analysi rel valuat multipl
downsid risk potenti on-line competit amazon erod front end comp margin us
pharmaci share continu reimburs pressur us eu hit ultim lead total margin compress
transact prove challeng increas volum /revenu store appear futil lead poor return
posit independ retail us becom disadvantag vertic integr peer capabl take notabl
share manag unabl locat creativ transact leav balanc sheet underutil limit total oper
growth beauti push ultim becom distract momentum build manag must revisit costli rebuild
articl articl
time dissemin octob
analyst elizabeth anderson suzi yoon primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
report approv and/or distribut evercor group evercor group licens broker-deal regul
industri regulatori author finra evercor isi intern limit lsi uk authoris regul unit
kingdom financi conduct author institut sale trade research busi evercor group lsi uk collect
oper global market brand name evercor lsi evercor lsi evercor group lsi uk subsidiari evercor inc
evercor trademark logo servic mark shown report regist trademark evercor
analyst associ respons prepar report receiv compens base variou factor includ evercor partner
total revenu portion gener affili invest bank transact evercor lsi seek updat research
appropri variou regul may prevent happen certain instanc asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgment
evercor lsi gener prohibit analyst associ member household maintain financi interest secur
compani analyst area coverag except polici requir specif approv member complianc
depart ownership subject complianc applic regul disclosur evercor lsi also prohibit analyst associ
member household serv offic director advisori board member employe compani analyst
report may includ tactic call describ near-term event catalyst affect subject compani market overal
expect short-term price impact equiti share subject compani tactic call separ analyst
long-term recommend outperform under-perform reflect stock forward expect return formal rate
may differ target price recommend reflect analyst long-term view
applic current disclosur regard subject compani cover report avail offic evercor lsi
